Cargando…
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials
AIMS: This study aimed to investigate the reporting of subgroup analyses in heart failure (HF) randomized controlled trials (RCTs) and to determine the strength and credibility of subgroup claims. METHODS AND RESULTS: All primary HF RCTs published in nine high‐impact journals from 1 January 2008 to...
Autores principales: | Khan, Muhammad Shahzeb, Khan, Muhammad Arbaz Arshad, Irfan, Simra, Siddiqi, Tariq Jamal, Greene, Stephen J., Anker, Stefan D., Sreenivasan, Jayakumar, Friede, Tim, Tahhan, Ayman Samman, Vaduganathan, Muthiah, Fonarow, Gregg C., Butler, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835611/ https://www.ncbi.nlm.nih.gov/pubmed/33254286 http://dx.doi.org/10.1002/ehf2.13122 |
Ejemplares similares
-
Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure
por: Usman, Muhammad Shariq, et al.
Publicado: (2022) -
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis
por: Butler, Javed, et al.
Publicado: (2020) -
Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020) -
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020) -
Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)